GVR Report cover In Vitro Diagnostics Market Size, Share & Trends Report

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By End-use (Hospitals, Laboratory), By Technology (Immunoassay, Coagulation), By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report ID: 978-1-68038-080-4
  • Number of Report Pages: 200
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2024
  • Forecast Period: 2025 - 2030 
  • Industry: Healthcare

In Vitro Diagnostics Market Size & Trends

The global in vitro diagnostics market size was estimated at USD 80.71 billion in 2024 and is projected to grow at a CAGR of 6.75% from 2025 to 2030. The growth can be attributed to the increasing adoption of in vitro diagnostics (IVD) owing to rise in the incidence of infectious and chronic diseases. The development of automated IVD systems for laboratories and hospitals to provide efficient, accurate, and error-free diagnoses is expected to fuel the growth. The rising number of IVD products launched by key players is also fueling the growth of the market.

In Vitro Diagnostics Market Size by Product, 2020 - 2030 (USD Billion)

For instance, In January 2024, ELITechGroup launched the CE-IVDR-certified GI Bacterial PLUS ELITe MGB Kit, marking a significant expansion of its in vitro diagnostic portfolio. This kit is the first in the company's Gastrointestinal (GI) assay panel, designed specifically to detect bacterial pathogens responsible for GI infections. In addition, ELITechGroup plans to introduce three additional kits in the upcoming quarter. These additions will encompass a full range of gastrointestinal infections, providing laboratories and healthcare professionals with comprehensive tools for accurate diagnosis and effective management of GI conditions.

Technological advancements in terms of accuracy, portability, and cost-effectiveness are expected to be one of the high-impact rendering drivers of this market. The introduction of novel and highly accurate clinical laboratory tests is increasing the adoption of novel IVD tests worldwide. In June 2023, Toray Industries, Inc. received marketing approval from Japan’s Ministry of Health, Labour and Welfare for its Toray APOA2-iTQ used to diagnose pancreatic cancer. Moreover, in March 2023, Abbott received U.S. FDA clearance for its novel laboratory Traumatic Brain Injury (TBI) blood test in the U.S. Increasing approvals of IVD tests for life-threatening diseases are expected to create new opportunities in the untapped market.

In addition, In July 2023, Siemens Healthineers introduced the Atellica CI Analyzer, a compact testing system designed for immunoassay and clinical chemistry testing. The Atellica CI Analyzer aims to address key challenges in laboratory operations, such as labor shortages, while also fostering revenue growth by enhancing lab agility beyond standardization and clinical equivalence. This advanced system streamlines workflow processes to help labs achieve more predictable turnaround times, reduce reporting burdens, and allow lab staff to focus on critical operational tasks. As the latest addition to Siemens Healthineers' Atellica in vitro diagnostics portfolio, the analyzer has received FDA clearance and is now accessible in major global markets. It is particularly advantageous for labs with low to medium testing volumes, providing them with competitive benefits such as improved turnaround time predictability, advanced reporting capabilities, and enhanced safety and security features.

Key players in the in vitro diagnostics market undertake various strategies to strengthen their position and offer their customers diverse, technologically advanced & innovative products. New product launches and partnerships are the most prominently adopted by companies to attract more customers in the IVD market. For instance, in March 2023, BD received 510(k) clearance for BD Vaginal Panel on the BD COR System to detect infectious causes of vaginitis. Similarly, in August 2023, the Precision Medicine Centre (PMC) partnership with the Regional Molecular Diagnostic Service (RMDS) to implement genomic technology for the diagnosis of cancer in Northern Ireland.

Moreover, in May 2024, bioMérieux announced that it received U.S. FDA 510(k) clearance for the VIDAS TBI (GFAP, UCH-L1), a serum-based test designed to assist in assessing patients with mild traumatic brain injury (mTBI), such as concussions. This innovative assay leverages a combination of two biomarkers, GFAP and UCH-L1, which are proteins that enter the bloodstream following cellular injury. The test offers a potential solution to reduce the number of unnecessary head CT scans for mTBI patients by predicting the absence of acute intracranial lesions (ICL). This advancement could significantly impact patient care by optimizing the use of imaging resources and reducing patient exposure to radiation.

Favorable initiatives undertaken by government and non-government bodies to improve overall healthcare services are anticipated to increase the market growth. In October 2023, the WHO published the Essential Diagnostics List (EDL), a comprehensive list of IVD products that helps countries make decisions regarding diagnostic tools. It provides evidence-based recommendations and ensures the accessibility of essential products for target people. Moreover, in August 2023, the Africa CDC collaborated with the Africa Development Agency-New Partnership for Africa's Development (AUDA-NEPAD) to increase access to diagnostic tests across Africa. Such initiatives are expected to increase the market uptake in developing regions.

Product Insights

Reagents held the largest revenue share of 67.07% in the market in 2024. The segment is expected to retain its dominance growing at the fastest CAGR during the forecast period owing to the extensive R&D initiatives undertaken by major market players to develop novel reagents and test kits. For instance, in February 2023, BD received the market approval for the BD Onclarity HPV Assay to be used with the ThinPrep Pap Test in the U.S. The increasing R&D activities to enable faster cancer detection and precision medicine is allowing companies to focus on niche profitable areas in the IVD business. For instance, in March 2023, QIAGEN partnered up with Servier to develop a companion diagnostic test for TIBSOVO, indicated for treating the blood cancer acute myeloid leukemia. The growth in precision medicine is projected to enhance the overall demand for such novel reagents and consumables.

Instruments held the second-largest revenue share in 2024. Increasing approvals for novel IVD instruments is anticipated to drive the segment growth. For instance, in April 2023, bioMérieux SA submitted 510(k) application to the U.S. FDA for VITEK REVEAL, rapid AST system. Players are aligning their instrument launches with the increasing genetic test requirement globally. For instance, in March 2022, Ion Torrent Genexus Dx Integrated Sequencer was introduced in the market by Thermo Fisher Scientific for research as well as diagnostic purposes.

Technology Insights

Immunoassay accounted for the largest revenue share of the market in 2024. The increasing incidence of chronic & communicable diseases and the rising need for early diagnosis are among the key factors leading to an increase in demand for immunological methods, including different Enzyme-Linked Immunosorbent Assays (ELISAs). Moreover, key players are focused on R&D for the development of new immunological diagnostic instruments and tests for IVD applications. For instance, in October 2023, Sysmex Corporation and Fujirebio Holdings, Inc. collaborated to enhance their R&D, production, clinical development, and marketing activities in immunoassay.

Coagulation is expected to grow at the fastest rate from 2025 to 2030. The growth of the segment can be attributed to the increasing prevalence of cardiovascular diseases, blood-related disorders, and autoimmune diseases. Moreover, the instruments are getting updated and handheld coagulation analyzers, such as the Xprecia stride coagulation analyzer, such instruments are anticipated to enhance the overall workflow of detection. Some of the key players offering instruments and coagulation tests are Abbott, Siemens Healthcare GmbH, and Beckman Coulter, Inc.

End-use Insights

Hospitals held the largest revenue share of the market in 2024, owing to a rise in hospitalizations that require support from faster diagnostics. Moreover, the ongoing development of healthcare infrastructure and favorable initiatives taken by government bodies are anticipated to enhance the existing hospital facilities. Thus, the demand for hospital-based IVD tests is increasing. Most IVD devices are purchased by hospitals and used in significant volumes. In 2023, there are over 6,129 hospitals in the U.S. that require constant aid from IVD for critical decision-making, as IVD tests provide faster and more accurate results. Moreover, in December 2023, the American Hospital Association wrote a letter to the FDA not to apply device regulations to hospital LDTs.

The homecare segment is expected to grow at a high CAGR from 2025 to 2030 due to the rising geriatric population and increasing demand for home care IVD devices. There is a growing need for novel molecular diagnostic and immunoassay platforms to assist patients in self-testing. For instance, in February 2023, the initial over-the-counter (OTC) home diagnostic test that can distinguish and identify influenza A and B, commonly referred to as the flu, and SARS-CoV-2, the virus causing COVID-19, was given an EUA by the FDA.

Application Insights

The infectious diseases segment dominated the market in 2024. The outbreak of the COVID-19 pandemic has increased the segment share significantly in recent years. Moreover, key players are introducing novel testing products to improve access to high-quality, innovative laboratory services for patients & healthcare providers. For instance, in February 2023, BD received EUA from the U.S. FDA for a new molecular diagnostic combination test for SARS-CoV-2, Influenza A+B, and Respiratory Syncytial Virus (RSV). Such initiatives by key players to strengthen their presence are expected to drive the market.

The oncology segment is anticipated to grow at the fastest rate from 2025 to 2030. The increasing incidence of cancer coupled with a high mortality rate is increasing the demand for cancer biomarker tests at an early stage. Moreover, increasing approval of novel tests, R&D activities, and favorable initiatives undertaken by regulatory bodies are expected to drive growth. For instance, in June 2023, the U.S. FDA announced a pilot program that gives chance to manufacturers to submit validation and performance data for LDTs for cancer. Moreover, in April 2023, Biocartis Group NV & APIS Assay Technologies Ltd. collaborated to manufacture and commercialize a breast cancer subtyping test on Idylla, a molecular diagnostics platform.

Test Location Insights

Others (lab-based tests) accounted for the largest revenue share of the market in 2024. A large number of test analyses at one time and the higher accuracy of laboratory-based tests make them more reliable compared to PoC and home tests, giving these tests a competitive edge over the other two segments. Moreover, the availability of tests that allow for sample collection at home and sending it to the laboratories for testing makes testing highly convenient for patients.

In Vitro Diagnostics Market Share by Test Location, 2024 (%)

The homecare segment is expected to grow at a high CAGR from 2025 to 2030 due increasing reliability of these tests and the patient-centric approaches of manufacturers. These tests have been an important source in mitigating the spread of the SARS-CoV-2 pandemic. Significant actions have been taken by government bodies globally to ensure access to affordable and efficient homecare tests. In April 2023, Llusern Scientific, a University of South Wales spinoff, developed the PoC molecular diagnostic platform, Lodestar Dx platform, for panel testing of urinary tract infections.

Regional Insights

North America In Vitro Diagnostics market dominated the global market and accounted for a 42.28% share in 2024. The region is estimated to retain its leading market position throughout the forecast period. The market in this region is collectively driven by factors such as the rising incidence of chronic diseases, the presence of strong market players, the increasing launch of novel tests, and supportive government funding. For instance, in January 2023, BD and CerTest Biotec received EUA from the U.S. FDA for a PCR test for Mpox virus detection in the U.S. Moreover, the increasing requirement for genetic testing for personalized health care, such as that for diabetes and cancer, is expected to further drive the market growth in North America.

In Vitro Diagnostics Market Trends, by Region, 2025 - 2030

U.S. In Vitro Diagnostics Market Trends

In vitro diagnostics market in the U.S. is growing steadily, driven by trends like personalized medicine, point-of-care testing, and advanced molecular diagnostics. Personalized medicine, which tailors treatments to individual genetic profiles, is gaining ground with IVD innovations like Roche's LightCycler PRO System. Point-of-care testing is also rising, enabling quicker diagnostics in settings outside traditional labs, as seen with Abbott's rapid COVID-19 tests. Additionally, molecular diagnostics, especially for cancer and infectious diseases, is expanding with tests like bioMérieux's VIDAS TBI, which aids in assessing traumatic brain injury.

Europe In Vitro Diagnostics Market Trends

The Europe in vitro diagnostics market is expanding, propelled by trends in infectious disease testing, molecular diagnostics, and compliance with regulatory standards like CE-IVDR. Demand for infectious disease diagnostics surged post-COVID-19, with companies like Siemens Healthineers advancing platforms like the Atellica CI Analyzer for efficient, compact testing. Molecular diagnostics are also booming, as seen with ELITechGroup’s CE-IVDR certified GI Bacterial PLUS kit, aimed at gastrointestinal infections. The strict IVDR regulation drives innovation, ensuring higher accuracy and safety in diagnostic tests across Europe.

In vitro diagnostics market in the UK is experiencing growth, driven by advancements in point-of-care testing, molecular diagnostics, and AI-powered solutions. Point-of-care testing has gained popularity, particularly in managing chronic diseases, as seen with Abbott’s handheld glucose monitors. Molecular diagnostics, such as Roche’s next-generation LightCycler PRO for precise genetic testing, are expanding to support personalized medicine initiatives. Additionally, AI integration in diagnostics is helping streamline workflows, enabling faster data analysis and interpretation, which is essential for enhancing patient care in both clinical and remote settings.

France IVD market is evolving rapidly, with strong trends in point-of-care testing, molecular diagnostics, and infectious disease assays. Point-of-care solutions, particularly for chronic disease management, are gaining traction in decentralized healthcare settings. The demand for molecular diagnostics, boosted by advancements like CE-IVDR compliance, is also expanding, especially in oncology and genetic testing. Infectious disease diagnostics remain a focal area, driven by heightened public health awareness and investment in rapid testing technologies to enhance outbreak response.

In vitro diagnostics market in Germany is advancing with trends in personalized medicine, molecular diagnostics, and automation in laboratory processes. The focus on personalized healthcare is propelling demand for molecular diagnostics, particularly in cancer genomics and infectious disease detection. Automation is also a key trend, with laboratories adopting advanced systems to streamline workflows, reduce error rates, and manage high sample volumes. Additionally, Germany's regulatory alignment with the EU’s IVDR standards is driving innovation and compliance in diagnostic devices and testing methods.

Asia Pacific In Vitro Diagnostics Market Trends

Asia Pacific in vitro diagnostics market is anticipated to exhibit significant growth at CAGR of 8.59% during the forecast period. The regional market of Asia Pacific is expected to be driven by a number of factors, some of which include the presence of stabilizing economies, a rapidly growing middle-class population, supportive government policies, and rapid urbanization across the region. For instance, in October 2023, Fapon and Halodoc partnered to increase the in vitro diagnostic products sales and services in Indonesia. Moreover, leading players are collaborating with regional players to expand their reach in developing countries in Asia Pacific.

In vitro diagnostics market in China is expanding rapidly, driven by a rising demand for molecular diagnostics, point-of-care testing, and digital health integration. Molecular diagnostics, especially in infectious diseases and oncology, are seeing significant growth due to public health initiatives and increased healthcare spending. Point-of-care testing is gaining momentum in rural and community health settings, providing accessible diagnostic options. Additionally, digital health and AI-driven diagnostics are being integrated to improve patient outcomes, streamline diagnostics, and support the country’s healthcare modernization efforts.

Japan in vitro diagnostics market is experiencing growth spurred by an aging population and advancements in personalized medicine. Key trends include the rising use of molecular diagnostics, particularly for oncology and genetic testing, as these help identify targeted treatments for age-related diseases. Automation and AI integration in diagnostic labs are also enhancing efficiency and accuracy, which is crucial given Japan’s limited healthcare workforce. Furthermore, there’s an increased demand for point-of-care testing, especially in home and community health settings, supporting proactive and preventive healthcare.

Latin America In Vitro Diagnostics Market Trends

In vitro diagnostics market in Latin America is growing due to rising healthcare investments, increased focus on disease prevention, and expanding healthcare access. A key trend is the rising adoption of point-of-care testing for infectious diseases like dengue, Zika, and COVID-19, crucial in remote and underserved areas. Additionally, demand for molecular diagnostics, particularly in oncology, is increasing as awareness of personalized medicine grows. Public-private partnerships and government initiatives are also supporting diagnostics infrastructure, making advanced testing technologies more accessible across the region.

The Brazil in vitro diagnostics market is experiencing significant growth, driven by advancements in technology, an aging population, and increasing prevalence of chronic diseases. Key trends include the rising demand for point-of-care testing, which offers rapid results and enhances patient management. Additionally, there is a growing focus on personalized medicine and molecular diagnostics, supported by government initiatives to improve healthcare infrastructure. The market is also witnessing increased investments in research and development, fostering innovation in diagnostic solutions.

Middle East & Africa In Vitro Diagnostics Market Trends

The In vitro diagnostics market in Middle East and Africa (MEA) is poised for growth, driven by rising healthcare expenditures and an increasing prevalence of infectious diseases. Key trends include the adoption of advanced molecular diagnostics and point-of-care testing, which enhance disease detection and management. Additionally, a growing focus on personalized medicine and government initiatives aimed at improving healthcare infrastructure are supporting market expansion. Collaborations between local and global players are also fostering innovation and enhancing the accessibility of diagnostic solutions in the region.

The Saudi Arabia in vitro diagnostics market is experiencing robust growth, fueled by a rising demand for advanced diagnostic solutions and an expanding healthcare infrastructure. Key trends include the increasing adoption of point-of-care testing and molecular diagnostics, which enhance disease detection and management. Additionally, government initiatives aimed at improving healthcare quality and accessibility are driving investments in the IVD sector. The growing prevalence of chronic and infectious diseases further propels market growth, alongside a focus on personalized medicine and innovative diagnostic technologies.

Key In Vitro Diagnostics Company Insights

Some key players operating in the market include F. Hoffmann-La Roche Ltd.; Abbott, Quest Diagnostics Incorporated; and Danaher, among others. Market players in the IVD market are adopting various market strategies such as new product launches, mergers & acquisitions, and partnerships to strengthen their product portfolios, offer diverse technologically advanced & innovative products, expand their product portfolios, and improve competency.

Llusern Scientific, Biocartis Group NV, ARUP Laboratories, Veracyte, and Exact Sciences Corp are some of the emerging market participants in the market. Emerging companies are actively involved in developing novel and accurate IVD testing products to improve overall health services. Moreover, these companies are collaborating with research institutes, government bodies, and global leaders to increase the range of their products in potential markets.

Key In Vitro Diagnostics Companies:

The following are the leading companies in the IVD market. These companies collectively hold the largest market share and dictate industry trends.

View a comprehensive list of companies in the In Vitro Diagnostics Market

Recent Developments

  • In January 2024, Cepheid's Xpert Xpress MVP received FDA clearance and CLIA waiver, offering rapid multiplex PCR testing for Bacterial Vaginosis (BV), Vulvovaginal Candidiasis (VVC), and Trichomoniasis (TV), improving targeted treatment and patient outcomes in near-patient settings.

  • In December 2023, ARUP Laboratories and Medicover collaborated to provide diagnostic and healthcare services in Europe. ARUP Laboratories has developed AAV5 DetectCDx in collaboration with BioMarin Pharmaceutical Inc. to select therapies for severe hemophilia A patients.

  • In November 2023, Veracyte joined Illumina aimed to develop molecular tests for decentralized IVD applications. Companies are focusing on the development of Prosigna breast cancer and Percepta nasal swab tests of Veracyte.

  • In October 2023, Promega Corporation announced its plan to develop and commercialize companion diagnostics kits with GSK plc to identify cancer patients with MSI-H solid tumors.

  • In February 2023, Unilabs announced investing over USD 200 million in Siemens Healthineers' technology and acquiring more than 400 laboratory analyzers to strengthen its laboratory infrastructure.

  • In February 2023, F. Hoffmann-La Roche Ltd. collaborated with Janssen Biotech Inc. to develop companion diagnostics for targeted therapies. Companion diagnostic technologies include digital pathology, NGS, PCR, immunoassays, and immunohistochemistry.

In Vitro Diagnostics Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 85.63 billion

Revenue forecast in 2030

USD 118.72 billion

Growth rate

CAGR of 6.75% from 2025 to 2030

Actual data

2018 - 2024

Forecast period

2025 - 2030

Quantitative units

Revenue in USD million/billion, volume (number of units installed and reagents sold), and CAGR from 2025 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Products, technology, application, end-use, test location, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; UK; Germany; France; Spain; Italy; Russia; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

Abbott; bioMérieux SA; QuidelOrtho Corporation; Siemens Healthineers AG; Bio-Rad Laboratories, Inc.; Qiagen; Sysmex Corporation; Charles River Laboratories; Quest Diagnostics Incorporated; Agilent Technologies, Inc.; Danaher Corporation; BD; F. Hoffmann-La Roche Ltd.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global In Vitro Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global in vitro diagnostics market report based on the products, technology, application, end-use, test location, and region.

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Instruments

    • Reagents

    • Services

  • Technology Outlook (Revenue, USD Million, 2018 - 2030)

    • Immunoassay

      • Instruments

      • Reagents

      • Services

    • Hematology

      • Instruments

      • Reagents

      • Services

    • Clinical Chemistry

      • Instruments

      • Reagents

      • Services

    • Molecular Diagnostics

      • Instruments

      • Reagents

      • Services

    • Coagulation

      • Instruments

      • Reagents

      • Services

    • Microbiology

      • Instruments

      • Reagents

      • Services

    • Others

      • Instruments

      • Reagents

      • Services

  • Application Outlook (Revenue, USD Million, 2018 - 2030)

    • Infectious Diseases

    • Diabetes

    • Oncology

    • Cardiology

    • Nephrology

    • Autoimmune Diseases

    • Drug Testing

    • Others applications

  • Test Location Outlook (Revenue, USD Million, 2018 - 2030)

    • Point of Care

    • Home-care

    • Others

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)

    • Hospitals

    • Laboratory

    • Home-care

    • Others

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Spain

      • Italy

      • Russia

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • South Korea

      • Australia

      • Thailand

      • Singapore

    • Latin America

      • Brazil

      • Argentina

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                        1.2.1. Product
                        1.2.2. Technology
                        1.2.3. Application
                        1.2.4. Test Location
                        1.2.5. End Use
                    1.3. Regional Scope
                    1.4. Estimates and Forecast Timeline
                    1.5. Research Methodology
                    1.6. Information Procurement
                        1.6.1. Purchased Database
                        1.6.2. GVR’s Internal Database
                    1.7. Details of primary research
                    1.8. Market Formulation & Validation
                    1.9. Model Details
                        1.9.1. Commodity flow analysis (Model 1)
                            1.9.1.1. Approach 1: Commodity flow approach
                        1.9.2. Volume price analysis (Model 2)
                            1.9.2.1. Approach 2: Volume price analysis
                    1.10. Research Scope and Assumptions
                        1.10.1. List of Secondary Sources
                        1.10.2. List of Primary Sources
                        1.10.3. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Drivers Analysis
                            3.2.1.1. Growing Geriatric Population
                            3.2.1.2. Technological Advancements
                            3.2.1.3. Increasing Demand For PoC Facilities
                            3.2.1.4. Growing prevalence of target diseases
                            3.2.1.5. Outbreak Of Covid-19
                        3.2.2. Market Restraints Analysis
                            3.2.2.1. Higher Cost Of Devices
                            3.2.2.2. Stringent Regulatory Policies
                    3.3. In Vitro Diagnostics Market Analysis Tools
                        3.3.1. Porter’s Analysis
                            3.3.1.1. Bargaining power of the suppliers
                            3.3.1.2. Bargaining power of the buyers
                            3.3.1.3. Threats of substitution
                            3.3.1.4. Threats from new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Economic and Social landscape
                            3.3.2.3. Technological landscape
                            3.3.2.4. Legal landscape
                    3.4. Consumer Behavior Analysis
                    3.5. Pricing Analysis
                        3.5.1. Instruments
                        3.5.2. Reagents
Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million) (Volume Analysis)
                    4.3. Instruments
                        4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold)
                    4.4. Reagents
                        4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests Sold)
                    4.5. Services
                        4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million) (Volume Analysis)
                    5.3. Immunoassay
                        5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.2. Instruments
                            5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.3. Reagents
                            5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.4. Services
                            5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.4. Hematology
                        5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.2. Instruments
                            5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.3. Reagents
                            5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.4. Services
                            5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Clinical Chemistry
                        5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.2. Instruments
                            5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.3. Reagents
                            5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.4. Services
                            5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.6. Molecular Diagnostics
                        5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.6.2. Instruments
                            5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.6.3. Reagents
                            5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.6.4. Services
                            5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.7. Coagulation
                        5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.7.2. Instruments
                            5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.7.3. Reagents
                            5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.7.4. Services
                            5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.8. Microbiology
                        5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.8.2. Instruments
                            5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.8.3. Reagents
                            5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.8.4. Services
                            5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.9. Others
                        5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.9.2. Instruments
                            5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.9.3. Reagents
                            5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.9.4. Services
                            5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
                    6.3. Infectious Disease
                        6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.4. Diabetes
                        6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Oncology/Cancer
                        6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.6. Cardiology
                        6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.7. Nephrology
                        6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.8. Autoimmune Diseases
                        6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.9. Drug Testing
                        6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.10. Others
                        6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2030 (USD Million)
                    7.3. Point of Care
                        7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.4. Home-care
                        7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.5. Others
                        7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis
                    8.1. Segment Dashboard
                    8.2. In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
                    8.3. Hospitals
                        8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.4. Laboratory
                        8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.5. Home Care
                        8.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.6. Others
                        8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
                    9.1. In Vitro Diagnostics Market Share, By Region, 2024 & 2030 (USD Million)
                    9.2. North America
                        9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.2.2. U.S.
                            9.2.2.1. Key Country Dynamics
                            9.2.2.2. Regulatory Landscape/Reimbursement Scenario
                            9.2.2.3. Competitive Insights
                            9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.2.3. Canada
                            9.2.3.1. Key Country Dynamics
                            9.2.3.2. Regulatory Landscape/Reimbursement Scenario
                            9.2.3.3. Competitive Insights
                            9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.2.4. Mexico
                            9.2.4.1. Key Country Dynamics
                            9.2.4.2. Regulatory Landscape/Reimbursement Scenario
                            9.2.4.3. Competitive Insights
                            9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                    9.3. Europe
                        9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.3.2. UK
                            9.3.2.1. Key Country Dynamics
                            9.3.2.2. Regulatory Landscape/Reimbursement Scenario
                            9.3.2.3. Competitive Insights
                            9.3.2.4. UK In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        9.3.3. Germany
                            9.3.3.1. Key Country Dynamics
                            9.3.3.2. Regulatory Landscape/Reimbursement Scenario
                            9.3.3.3. Competitive Insights
                            9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.3.4. France
                            9.3.4.1. Key Country Dynamics
                            9.3.4.2. Regulatory Landscape/Reimbursement Scenario
                            9.3.4.3. Competitive Insights
                            9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.3.5. Italy
                            9.3.5.1. Key Country Dynamics
                            9.3.5.2. Regulatory Landscape/Reimbursement Scenario
                            9.3.5.3. Competitive Insights
                            9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.3.6. Spain
                            9.3.6.1. Key Country Dynamics
                            9.3.6.2. Regulatory Landscape/Reimbursement Scenario
                            9.3.6.3. Competitive Insights
                            9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.3.7. Sweden
                            9.3.7.1. Key Country Dynamics
                            9.3.7.2. Regulatory Landscape/Reimbursement Scenario
                            9.3.7.3. Competitive Insights
                            9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.3.8. Denmark
                            9.3.8.1. Key Country Dynamics
                            9.3.8.2. Regulatory Landscape/Reimbursement Scenario
                            9.3.8.3. Competitive Insights
                            9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.3.9. Norway
                            9.3.9.1. Key Country Dynamics
                            9.3.9.2. Regulatory Landscape/Reimbursement Scenario
                            9.3.9.3. Competitive Insights
                            9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.3.10. Russia
                            9.3.10.1. Key Country Dynamics
                            9.3.10.2. Regulatory Landscape/Reimbursement Scenario
                            9.3.10.3. Competitive Insights
                            9.3.10.4. Russis In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                    9.4. Asia Pacific
                        9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.4.2. China
                            9.4.2.1. Key Country Dynamics
                            9.4.2.2. Regulatory Landscape/Reimbursement Scenario
                            9.4.2.3. Competitive Insights
                            9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.4.3. Japan
                            9.4.3.1. Key Country Dynamics
                            9.4.3.2. Regulatory Landscape/Reimbursement Scenario
                            9.4.3.3. Competitive Insights
                            9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.4.4. India
                            9.4.4.1. Key Country Dynamics
                            9.4.4.2. Regulatory Landscape/Reimbursement Scenario
                            9.4.4.3. Competitive Insights
                            9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.4.5. South Korea
                            9.4.5.1. Key Country Dynamics
                            9.4.5.2. Regulatory Landscape/Reimbursement Scenario
                            9.4.5.3. Competitive Insights
                            9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.4.6. Australia
                            9.4.6.1. Key Country Dynamics
                            9.4.6.2. Regulatory Landscape/Reimbursement Scenario
                            9.4.6.3. Competitive Insights
                            9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.4.7. Thailand
                            9.4.7.1. Key Country Dynamics
                            9.4.7.2. Regulatory Landscape/Reimbursement Scenario
                            9.4.7.3. Competitive Insights
                            9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.4.8. Singapore
                            9.4.8.1. Key Country Dynamics
                            9.4.8.2. Regulatory Landscape/Reimbursement Scenario
                            9.4.8.3. Competitive Insights
                            9.4.8.4. Singapore In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                    9.5. Latin America
                        9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.5.2. Brazil
                            9.5.2.1. Key Country Dynamics
                            9.5.2.2. Regulatory Landscape/Reimbursement Scenario
                            9.5.2.3. Competitive Insights
                            9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.5.3. Argentina
                            9.5.3.1. Key Country Dynamics
                            9.5.3.2. Regulatory Landscape/Reimbursement Scenario
                            9.5.3.3. Competitive Insights
                            9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                    9.6. Middle East and Africa
                        9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        9.6.2. Saudi Arabia
                            9.6.2.1. Key Country Dynamics
                            9.6.2.2. Regulatory Landscape/Reimbursement Scenario
                            9.6.2.3. Competitive Insights
                            9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.6.3. UAE
                            9.6.3.1. Key Country Dynamics
                            9.6.3.2. Regulatory Landscape/Reimbursement Scenario
                            9.6.3.3. Competitive Insights
                            9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.6.4. South Africa
                            9.6.4.1. Key Country Dynamics
                            9.6.4.2. Regulatory Landscape/Reimbursement Scenario
                            9.6.4.3. Competitive Insights
                            9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
                        9.6.5. Kuwait
                            9.6.5.1. Key Country Dynamics
                            9.6.5.2. Regulatory Landscape/Reimbursement Scenario
                            9.6.5.3. Competitive Insights
                            9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
Chapter 10. Competitive Landscape
                    10.1. Recent Developments & Impact Analysis by Key Market Participants
                    10.2. Company Categorization
                    10.3. Global Company Market Share Analysis, 2024
                    10.4. Company Heat Map Analysis
                    10.5. Strategy Mapping
                        10.5.1. Expansion
                        10.5.2. Mergers & Acquisition
                        10.5.3. Partnerships & Collaborations
                        10.5.4. New Product Launches
                        10.5.5. Research And Development
                    10.6. Company Profiles
                        10.6.1. QIAGEN
                            10.6.1.1. Participant’s Overview
                            10.6.1.2. Financial Performance
                            10.6.1.3. Product Benchmarking
                            10.6.1.4. Recent Developments
                        10.6.2. BD
                            10.6.2.1. Participant’s Overview
                            10.6.2.2. Financial Performance
                            10.6.2.3. Product Benchmarking
                            10.6.2.4. Recent Developments
                        10.6.3. bioMérieux SA
                            10.6.3.1. Participant’s Overview
                            10.6.3.2. Financial Performance
                            10.6.3.3. Product Benchmarking
                            10.6.3.4. Recent Developments
                        10.6.4. F. Hoffmann-La Roche, Ltd.
                            10.6.4.1. Participant’s Overview
                            10.6.4.2. Financial Performance
                            10.6.4.3. Product Benchmarking
                            10.6.4.4. Recent Developments
                        10.6.5. QuidelOrtho Corporation
                            10.6.5.1. Participant’s Overview
                            10.6.5.2. Financial Performance
                            10.6.5.3. Product Benchmarking
                            10.6.5.4. Recent Developments
                        10.6.6. Abbott
                            10.6.6.1. Participant’s Overview
                            10.6.6.2. Financial Performance
                            10.6.6.3. Product Benchmarking
                            10.6.6.4. Recent Developments
                        10.6.7. Agilent Technologies, Inc.
                            10.6.7.1. Participant’s Overview
                            10.6.7.2. Financial Performance
                            10.6.7.3. Product Benchmarking
                            10.6.7.4. Recent Developments
                        10.6.8. Siemens Healthineers AG
                            10.6.8.1. Participant’s Overview
                            10.6.8.2. Financial Performance
                            10.6.8.3. Product Benchmarking
                            10.6.8.4. Recent Developments
                        10.6.9. Bio-Rad Laboratories, Inc.
                            10.6.9.1. Participant’s Overview
                            10.6.9.2. Financial Performance
                            10.6.9.3. Product Benchmarking
                            10.6.9.4. Recent Developments
                        10.6.10. Danaher
                            10.6.10.1. Participant’s Overview
                            10.6.10.2. Financial Performance
                            10.6.10.3. Product Benchmarking
                            10.6.10.4. Recent Developments
                        10.6.11. Sysmex Corporation
                            10.6.11.1. Participant’s Overview
                            10.6.11.2. Financial Performance
                            10.6.11.3. Product Benchmarking
                            10.6.11.4. Recent Developments
                        10.6.12. Charles River Laboratories
                            10.6.12.1. Participant’s Overview
                            10.6.12.2. Financial Performance
                            10.6.12.3. Product Benchmarking
                            10.6.12.4. Recent Developments
                        10.6.13. Quest Diagnostics Incorporated
                            10.6.13.1. Participant’s Overview
                            10.6.13.2. Financial Performance
                            10.6.13.3. Product Benchmarking
                            10.6.13.4. Recent Developments


List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global In Vitro Diagnostics Market, By Region, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million) 
Table 5 Global In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 6 Global In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 7 Global In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 8 Global In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 9 Global In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 10 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 11 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 12 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 13 North America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 14 North America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 15 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 16 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 18 U.S. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 19 U.S. In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 21 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 22 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 23 Canada In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 24 Canada In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 26 Mexico In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 27 Mexico In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 28 Mexico In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 29 Mexico In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 30 Mexico In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 31 Europe In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 32 Europe In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 33 Europe In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 34 Europe In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 35 Europe In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 36 Europe In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 37 UK In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 38 UK In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 39 UK In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 40 UK In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 41 UK In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 42 Germany In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 43 Germany In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 44 Germany In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 45 Germany America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 46 Germany In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 47 France In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 48 France In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 49 France In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 50 France In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 51 France In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 52 Spain In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 53 Spain In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 54 Spain In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 55 Spain In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 56 Spain In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 57 Italy In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 58 Italy In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 58 Italy In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 60 Italy In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 61 Italy In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 62 Russia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 63 Russia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 64 Russia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 65 Russia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 66 Russia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 67 Asia Pacific In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 68 Asia Pacific In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 69 Asia Pacific In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 70 Asia Pacific In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 71 Asia-Pacific In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 72 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 73 China In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 74 China In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 75 China In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 76 China In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 77 China In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 78 Japan In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 79 Japan In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 80 Japan In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 81 Japan In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 82 Japan In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 83 India In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 84 India In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 85 India In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 86 India In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 86 India In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 88 South Korea In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 89 South Korea In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 90 South Korea In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 91 South Korea In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 92 South Korea In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 93 Singapore In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 94 Singapore In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 95 Singapore In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 96 Singapore In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 97 Singapore In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 98 Australia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 99 Australia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 100 Australia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 101 Australia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 102 Australia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 103 Latin America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 104 Latin America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 105 Latin America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 106 Latin America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 107 Latin America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 108 Latin America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 109 Brazil In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 110 Brazil In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 111 Brazil In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 112 Brazil In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 113 Brazil In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 114 Argentina In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 115 Argentina In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 116 Argentina In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 117 Argentina In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 118 Argentina In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 119 MEA In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 120 MEA In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 121 MEA In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 122 MEA In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 123 MEA In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 124 MEA In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 125 South Africa In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 126 South Africa In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 127 South Africa In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 128 South Africa In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 129 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 130 UAE In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 131 UAE In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 132 UAE In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 133 UAE In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 134 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
Table 135 Saudi Arabia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 136 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 137 Saudi Arabia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 138 Saudi Arabia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Table 139 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)


List of Figures

Fig. 1 In Vitro Diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 In vitro diagnostic market snapshot
Fig. 10 Parent market outlook, 2024
Fig. 11 Penetration and growth prospect mapping
Fig. 12 In vitro diagnostic market driver impact
Fig. 13 Global elderly population
Fig. 14 New cancer cases by year
Fig. 15 In vitro diagnostic market restraint impact
Fig. 16 Market entry strategy
Fig. 17 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 18 Porter’s five forces analysis
Fig. 19 Consumer behavior analysis
Fig. 20 Strategy mapping
Fig. 21 IVD market: Product outlook and key takeaways
Fig. 22 IVD market: Products movement analysis
Fig. 23 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands)
Fig. 24 Reagents market estimates and forecast, 2018 - 2030 (USD Million), Number of reagents sold in millions
Fig. 25 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 IVD market: Technology outlook and key takeaways
Fig. 27 IVD Market: Technology movement analysis
Fig. 28 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 29 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Hematology market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 33 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Services market for hematology estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 37 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 41 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Coagulation market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 45 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Microbiology market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 49 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Others market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 53 Instruments others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Reagents others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 IVD market: Application outlook and key takeaways
Fig. 57 IVD market: Application movement analysis
Fig. 58 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Drug testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 IVD market: End-use outlook and key takeaways
Fig. 67 IVD treatment market: End-use movement analysis
Fig. 68 Hospitals market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 69 Laboratory market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 70 Home care market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 71 Other market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 72 IVD market: test location outlook and key takeaways
Fig. 73 IVD treatment market: Test location movement analysis
Fig. 74 Point-of-care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 IVD Market: Regional outlook and key takeaways
Fig. 78 IVD market: Regional movement analysis
Fig. 79 North America
Fig. 80 North America, SWOT
Fig. 81 North America. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 82 U.S. key country dynamics
Fig. 83 U.S. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 84 Canada key country dynamics
Fig. 85 Canada market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 86 Mexico key country dynamics
Fig. 87 Mexico market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 88 Europe
Fig. 89 Europe, SWOT
Fig. 90 Europe market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 91 U.K. key country dynamics
Fig. 92 U.K. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 93 Germany key country dynamics
Fig. 94 Germany market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 95 Spain key country dynamics
Fig. 96 Spain market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 97 France key country dynamics
Fig. 98 France market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 99 Italy key country dynamics
Fig. 100 Italy market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 101 Russia key country dynamics
Fig. 102 Russia market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 103 Denmark key country dynamics
Fig. 104 Denmark market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 105 Sweden key country dynamics
Fig. 106 Sweden market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 107 Norway key country dynamics
Fig. 108 Norway market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 109 Asia Pacific
Fig. 110 Asia Pacific, SWOT
Fig. 111 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 112 Japan key country dynamics
Fig. 113 Japan market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 114 China key country dynamics
Fig. 115 China. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 116 India key country dynamics
Fig. 117 India. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 118 South Korea key country dynamics
Fig. 119 South Korea market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 120 Singapore key country dynamics
Fig. 121 Singapore market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 122 Thailand key country dynamics
Fig. 123 Thailand market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 124 Australia key country dynamics
Fig. 125 Australia market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 126 Latin America
Fig. 127 Latin America, SWOT
Fig. 128 Latin America market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 129 Brazil key country dynamics
Fig. 130 Brazil market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 131 Argentina key country dynamics
Fig. 132 Argentina market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 133 Middle East & Africa
Fig. 134 Middle East & Africa, SWOT
Fig. 135 MEA market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 136 South Africa key country dynamics
Fig. 137 South Africa market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 138 United Arab Emirates key country dynamics
Fig. 139 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 140 Saudi Arabia key country dynamics
Fig. 141 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
Fig. 142 Ansoff matrix
Fig. 143 Competition categorization
Fig. 144 Company market share analysis, 2024
Fig. 145 Global mass spectrometry company market share analysis, 2024
Fig. 146 North America mass spectrometry company market share analysis, 2024
Fig. 147 Europe mass spectrometry company market share analysis, 2024
Fig. 148 Asia Pacific mass spectrometry company market share analysis, 2024
Fig. 149 Global immunoassay company market share analysis, 2024
Fig. 150 North America immunoassay company market share analysis, 2024
Fig. 151 Europe immunoassay company market share analysis, 2024
Fig. 152 Asia Pacific immunoassay company market share analysis, 2024
Fig. 153 Global PCR company market share analysis, 2024
Fig. 154 North America PCR company market share analysis, 2024
Fig. 155 Europe PCR company market share analysis, 2024
Fig. 156 Asia Pacific PCR company market share analysis, 2024
Fig. 157 Company market position analysis
Fig. 158 Company market position analysis
Fig. 159 Company market position analysis
Fig. 160 Company profiles
Fig. 161 Regional network map

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • In Vitro Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • Instruments
    • Reagents
    • Services
  • Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)
    • Immunoassay
      • Instruments
      • Reagents
      • Services
    • Hematology
      • Instruments
      • Reagents
      • Services
    • Clinical Chemistry
      • Instruments
      • Reagents
      • Services
    • Molecular Diagnostics
      • Instruments
      • Reagents
      • Services
    • Coagulation
      • Instruments
      • Reagents
      • Services
    • Microbiology
      • Instruments
      • Reagents
      • Services
    • Others
      • Instruments
      • Reagents
      • Services
  • In Vitro Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Infectious Diseases
    • Diabetes
    • Oncology
    • Cardiology
    • Nephrology
    • Autoimmune Diseases
    • Drug Testing
    • Other applications
  • In Vitro Diagnostics Test Location Outlook (Revenue, USD Million, 2018 - 2030)
    • Point of Care
    • Home-care
    • Others
  • In Vitro Diagnostics End Use Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospitals
    • Laboratory
    • Home Care
    • Others
  • In Vitro Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • North America
      • North America In Vitro Diagnostics Market, By Product
        • Instruments
        • Reagents
        • Services
      • North America In Vitro Diagnostics Market, By Technology
        • Immunoassay
          • Instruments
          • Reagents
          • Services
        • Hematology
          • Instruments
          • Reagents
          • Services
        • Clinical Chemistry
          • Instruments
          • Reagents
          • Services
        • Molecular Diagnostics
          • Instruments
          • Reagents
          • Services
        • Coagulation
          • Instruments
          • Reagents
          • Services
        • Microbiology
          • Instruments
          • Reagents
          • Services
        • Others
          • Instruments
          • Reagents
          • Services
      • North America In Vitro Diagnostics Market, By Application
        • Infectious Disease
        • Diabetes
        • Oncology/Cancer
        • Cardiology
        • Nephrology
        • Autoimmune Diseases
        • Drug Testing
        • Others
      • North America In Vitro Diagnostics Market, By Test Location
        • Point of Care
        • Home-care
        • Others
      • North America In Vitro Diagnostics Market, By End Use
        • Hospitals
        • Laboratory
        • Home Care
        • Others
      • U.S.
        • U.S. In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • U.S. In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • U.S. In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • U.S. In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • U.S. In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Canada
        • Canada In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Canada In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Canada In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Canada In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Canada In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Mexico
        • Mexico In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Mexico In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Mexico In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Mexico In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Mexico In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
    • Europe
      • Europe In Vitro Diagnostics Market, By Product
        • Instruments
        • Reagents
        • Services
      • Europe In Vitro Diagnostics Market, By Technology
        • Immunoassay
          • Instruments
          • Reagents
          • Services
        • Hematology
          • Instruments
          • Reagents
          • Services
        • Clinical Chemistry
          • Instruments
          • Reagents
          • Services
        • Molecular Diagnostics
          • Instruments
          • Reagents
          • Services
        • Coagulation
          • Instruments
          • Reagents
          • Services
        • Microbiology
          • Instruments
          • Reagents
          • Services
        • Others
          • Instruments
          • Reagents
          • Services
      • Europe In Vitro Diagnostics Market, By Application
        • Infectious Disease
        • Diabetes
        • Oncology/Cancer
        • Cardiology
        • Nephrology
        • Autoimmune Diseases
        • Drug Testing
        • Others
      • Europe In Vitro Diagnostics Market, By Test Location
        • Point of Care
        • Home-care
        • Others
      • Europe In Vitro Diagnostics Market, By End Use
        • Hospitals
        • Laboratory
        • Home Care
        • Others
      • UK
        • UK In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • UK In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • UK In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • UK In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • UK In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Germany
        • Germany In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Germany In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Germany In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Germany In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Germany In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • France
        • France In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • France In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • France In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • France In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • France In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Spain
        • Spain In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Spain In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Spain In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Spain In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Spain In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Italy
        • Italy In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Italy In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Italy In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Italy In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Italy In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Russia
        • Russia In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Russia In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Russia In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Russia In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Russia In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Denmark
        • Denmark In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Denmark In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Denmark In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Denmark In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Denmark In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Sweden
        • Sweden In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Sweden In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Sweden In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Sweden In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Sweden In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Norway
        • Norway In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Norway In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Norway In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Norway In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Norway In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
    • Asia Pacific
      • Asia Pacific In Vitro Diagnostics Market, By Product
        • Instruments
        • Reagents
        • Services
      • Asia Pacific In Vitro Diagnostics Market, By Technology
        • Immunoassay
          • Instruments
          • Reagents
          • Services
        • Hematology
          • Instruments
          • Reagents
          • Services
        • Clinical Chemistry
          • Instruments
          • Reagents
          • Services
        • Molecular Diagnostics
          • Instruments
          • Reagents
          • Services
        • Coagulation
          • Instruments
          • Reagents
          • Services
        • Microbiology
          • Instruments
          • Reagents
          • Services
        • Others
          • Instruments
          • Reagents
          • Services
      • Asia Pacific In Vitro Diagnostics Market, By Application
        • Infectious Disease
        • Diabetes
        • Oncology/Cancer
        • Cardiology
        • Nephrology
        • Autoimmune Diseases
        • Drug Testing
        • Others
      • Asia Pacific In Vitro Diagnostics Market, By Test Location
        • Point of Care
        • Home-care
        • Others
      • Asia Pacific In Vitro Diagnostics Market, By End Use
        • Hospitals
        • Laboratory
        • Home Care
        • Others
      • Japan
        • Japan In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Japan In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Japan In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Japan In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Japan In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • China
        • China In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • China In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • China In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • China In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • China In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • India
        • India In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • India In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • North America In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • India In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • India In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • South Korea
        • South Korea In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • South Korea In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • South Korea In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • South Korea In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • South Korea In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Australia
        • Australia In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Australia In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Australia In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Australia In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Australia In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Thailand
        • Thailand In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Thailand In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Thailand In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Thailand In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Thailand In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Singapore
        • Singapore In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Singapore In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Singapore In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Singapore In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Singapore In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
    • Latin America
      • Latin America In Vitro Diagnostics Market, By Product
        • Instruments
        • Reagents
        • Services
      • Latin America In Vitro Diagnostics Market, By Technology
        • Immunoassay
          • Instruments
          • Reagents
          • Services
        • Hematology
          • Instruments
          • Reagents
          • Services
        • Clinical Chemistry
          • Instruments
          • Reagents
          • Services
        • Molecular Diagnostics
          • Instruments
          • Reagents
          • Services
        • Coagulation
          • Instruments
          • Reagents
          • Services
        • Microbiology
          • Instruments
          • Reagents
          • Services
        • Others
          • Instruments
          • Reagents
          • Services
      • Latin America In Vitro Diagnostics Market, By Application
        • Infectious Disease
        • Diabetes
        • Oncology/Cancer
        • Cardiology
        • Nephrology
        • Autoimmune Diseases
        • Drug Testing
        • Others
      • Latin America In Vitro Diagnostics Market, By Test Location
        • Point of Care
        • Home-care
        • Others
      • Latin America In Vitro Diagnostics Market, By End Use
        • Hospitals
        • Laboratory
        • Home Care
        • Others
      • Brazil
        • Brazil In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Brazil In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Brazil In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Brazil In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • North America In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Argentina
        • Argentina In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Argentina In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Argentina In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Argentina In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Argentina In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
    • Middle East and Africa (MEA)
      • Middle East and Africa (MEA) In Vitro Diagnostics Market, By Product
        • Instruments
        • Reagents
        • Services
      • Middle East and Africa (MEA) In Vitro Diagnostics Market, By Technology
        • Immunoassay
          • Instruments
          • Reagents
          • Services
        • Hematology
          • Instruments
          • Reagents
          • Services
        • Clinical Chemistry
          • Instruments
          • Reagents
          • Services
        • Molecular Diagnostics
          • Instruments
          • Reagents
          • Services
        • Coagulation
          • Instruments
          • Reagents
          • Services
        • Microbiology
          • Instruments
          • Reagents
          • Services
        • Others
          • Instruments
          • Reagents
          • Services
      • Middle East and Africa (MEA) In Vitro Diagnostics Market, By Application
        • Infectious Disease
        • Diabetes
        • Oncology/Cancer
        • Cardiology
        • Nephrology
        • Autoimmune Diseases
        • Drug Testing
        • Others
      • Middle East and Africa (MEA) In Vitro Diagnostics Market, By Test Location
        • Point of Care
        • Home-care
        • Others
      • Middle East and Africa (MEA) In Vitro Diagnostics Market, By End Use
        • Hospitals
        • Laboratory
        • Home Care
        • Others
      • South Africa
        • South Africa In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • South Africa In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • South Africa In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • South Africa In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • South Africa In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Saudi Arabia
        • Saudi Arabia In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Saudi Arabia In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Saudi Arabia In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Saudi Arabia In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Saudi Arabia In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • UAE
        • UAE In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • UAE In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • UAE In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • UAE In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • UAE In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others
      • Kuwait
        • Kuwait In Vitro Diagnostics Market, By Product
          • Instruments
          • Reagents
          • Services
        • Kuwait In Vitro Diagnostics Market, By Technology
          • Immunoassay
            • Instruments
            • Reagents
            • Services
          • Hematology
            • Instruments
            • Reagents
            • Services
          • Clinical Chemistry
            • Instruments
            • Reagents
            • Services
          • Molecular Diagnostics
            • Instruments
            • Reagents
            • Services
          • Coagulation
            • Instruments
            • Reagents
            • Services
          • Microbiology
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Kuwait In Vitro Diagnostics Market, By Application
          • Infectious Disease
          • Diabetes
          • Oncology/Cancer
          • Cardiology
          • Nephrology
          • Autoimmune Diseases
          • Drug Testing
          • Others
        • Kuwait In Vitro Diagnostics Market, By Test Location
          • Point of Care
          • Home-care
          • Others
        • Kuwait In Vitro Diagnostics Market, By End Use
          • Hospitals
          • Laboratory
          • Home Care
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

Grand View Research employs a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. The company utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. In Addition, a recurring theme prevalent across all our research reports is data triangulation that looks market from three different perspectives. Critical elements of the methodology employed for all our studies include:

Preliminary data mining

Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For a comprehensive understanding of the market, it is essential to understand the complete value chain, and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.

Technical issues and trends are obtained from surveys, technical symposia, and trade journals. Technical data is also gathered from an intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.

Statistical model

Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression, and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, industry experience, and domain expertise.

Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of the technology landscape, regulatory frameworks, economic outlook, and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:

    • Market drivers and restraints, along with their current and expected impact
    • Raw material scenario and supply v/s price trends
    • Regulatory scenario and expected developments
    • Current capacity and expected capacity additions up to 2030

We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.

Primary validation

This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts, and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation but also provide critical insights into the market, current business scenario, and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:

    • Market-leading companies
    • Raw material suppliers
    • Product distributors
    • Buyers

The key objectives of primary research are as follows:

    • To validate our data in terms of accuracy and acceptability
    • To gain an insight in to the current market and future expectations

Data Collection Matrix

Perspective

Primary research

Secondary research

Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data

Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Industry Analysis Matrix

Qualitative analysis

Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2030
  • Market revenue estimates and forecasts up to 2030, by technology
  • Market revenue estimates and forecasts up to 2030, by application
  • Market revenue estimates and forecasts up to 2030, by type
  • Market revenue estimates and forecasts up to 2030, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

 

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
Jump to content
pdf icn

GET A FREE SAMPLE

arrow icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Or view our licence options:

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.